<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">HJCET</journal-id><journal-title-group><journal-title>Hans Journal of Chemical Engineering and Technology</journal-title></journal-title-group><issn pub-type="epub">2161-8844</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/HJCET.2017.75029</article-id><article-id pub-id-type="publisher-id">HJCET-21876</article-id><article-categories><subj-group subj-group-type="heading"><subject>HJCET20170500000_86279078.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>工程技术</subject></subj-group></article-categories><title-group><article-title>
 
 
  度洛西汀中间体(S)-3-甲基氨基-1-(噻吩-2-基)丙醇合成工艺综述
  Overview on the Synthesis of (S)-3-(Methyl-Amino)-1-(Thiophen-2-yl) Propan-1-ol
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>吴</surname><given-names>佳佳</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>季</surname><given-names>程宇</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>谢</surname><given-names>童杰</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>马</surname><given-names>良秀</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>郝</surname><given-names>之奎</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>徐</surname><given-names>峰</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>台州职业技术学院化学制药研究所，浙江 台州</addr-line></aff><aff id="aff3"><addr-line>浙江新东港药业股份有限公司，浙江 台州</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>30</day><month>08</month><year>2017</year></pub-date><volume>07</volume><issue>05</issue><fpage>199</fpage><lpage>204</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   (S)-3-甲基氨基-1-(噻吩-2-基)丙醇是抗抑郁药度洛西汀的重要中间体。本文根据起始原料的不同，将其合成方法概括为：乙酰噻吩法、噻吩法和噻吩甲醛法，分析了各种方法的工艺特点，并指出了(S)-3-甲基氨基-1-(噻吩-2-基)丙醇未来的发展趋势。 (S)-3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol is a class of important intermediate for anti-depressant R-Duloxetine. This paper summarized several methods to synthetize the compound according to its starting materials: starting from acetylthiophene, starting from thiophene, start-ing from thiophenecarboxaldehyde. The features of each method were analyzed. Finally, the de-velopment in the synthesis technology of (S)-3-(Methylamino)-1-(thiophen-2-yl) propan-1-ol was proposed. 
  
 
</p></abstract><kwd-group><kwd>酶法，均相不对称催化剂，合成，度洛西汀, Enzymic Method</kwd><kwd> Asymmetry of Homogeneous Catalysts</kwd><kwd> Synthesis</kwd><kwd> Duloxetine</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>度洛西汀中间体(S)-3-甲基氨基-1-(噻吩-2-基)丙醇合成工艺综述<sup> </sup></title><p>吴佳佳<sup>1</sup>，季程宇<sup>1</sup>，谢童杰<sup>1</sup>，马良秀<sup>2</sup>，郝之奎<sup>1</sup>，徐峰<sup>1*</sup></p><p><sup>1</sup>台州职业技术学院化学制药研究所，浙江 台州</p><p><sup>2</sup>浙江新东港药业股份有限公司，浙江 台州</p><p>收稿日期：2017年8月13日；录用日期：2017年8月24日；发布日期：2017年8月30日</p><disp-formula id="hanspub.21876-formula28"><graphic xlink:href="http://html.hanspub.org/file/3-1550334x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>(S)-3-甲基氨基-1-(噻吩-2-基)丙醇是抗抑郁药度洛西汀的重要中间体。本文根据起始原料的不同，将其合成方法概括为：乙酰噻吩法、噻吩法和噻吩甲醛法，分析了各种方法的工艺特点，并指出了(S)-3-甲基氨基-1-(噻吩-2-基)丙醇未来的发展趋势。</p><p>关键词 :酶法，均相不对称催化剂，合成，度洛西汀</p><disp-formula id="hanspub.21876-formula29"><graphic xlink:href="http://html.hanspub.org/file/3-1550334x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2017 by authors and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="http://image.hanspub.org:8080\Html/htmlimages\1-2890033x\e70a10f1-7c93-45ea-9603-062237856e4b.png" /><img src="http://image.hanspub.org:8080\Html\htmlimages\1-2890033x\e898c85e-ffc4-45c9-b817-14224a4d6960.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>度洛西汀(Duloxetine)是由美国礼来公司(Elililly)开发的一种安全有效的抗抑郁剂，是一种5-羟色胺和去甲肾上腺素双重再吸收抑制剂。随着全球抑郁人数越来越多，对于高效低毒的抗抑郁药的需求越来越大。相比于其他抗抑郁药物，如帕罗西汀、氟西汀和瑞波西汀等，度洛西汀具有更好的安全性和耐受性，更少的不良反应，且具有多样的治疗活性，因而销量逐年提高 [<xref ref-type="bibr" rid="hanspub.21876-ref1">1</xref>] ，现已占据全球抗抑郁药销量榜的第一的宝座。</p><p>为此，众多研究者致力于度洛西汀及其中间体的合成路线的探索，旨在寻找一条经济、环保、操作简单以及高收率的合成路线。其中，(S)-3-甲基氨基-1-(噻吩-2-基)丙醇(I)，作为合成度洛西汀的关键中间体(图1)，已成为众多研究者近年来关注热点。</p></sec><sec id="s4"><title>2. 度洛西汀关键中间体(S)-3-甲基氨基-1-(噻吩-2-基)丙醇的合成工艺</title><p>本文根据不同的起始原料，将(S)-3-甲基氨基-1-(噻吩-2-基)丙醇的合成方法分为乙酰噻吩法、噻吩法以及噻吩甲醛法。</p><sec id="s4_1"><title>2.1. 乙酰噻吩法</title><p>以乙酰噻吩为原料，主要有两种方法：一种是与三聚甲醛或多聚甲醛和胺通过Mannich缩合，再经</p><p>图1. 度洛西汀的一般合成路线</p><p>过不对称还原、进一步脱保护基得到目标产品；或者是通过溴代、还原、水解、环合以及开环得到目标产品。前者根据所用胺分为甲胺盐酸盐法和甲胺保护基法，后者一般为乙酰噻吩溴代法。</p><sec id="s4_1_1"><title>2.1.1. 甲胺盐酸盐法</title><p>此法将乙酰噻吩、三聚甲醛或多聚甲醛和甲胺盐酸盐通过Mannich法得到(S)-3-甲基氨基-1-(噻吩-2-基)丙酮盐酸盐，再经过不对称催化反应得到目标产品(图2)。其中不对称催化剂常用金属不对称催化剂或酶。常见的金属不对称催化剂有：(1, 5-环辛二烯)四氟硼酸铑(I) [<xref ref-type="bibr" rid="hanspub.21876-ref2">2</xref>] ，二氯{(R)-(+)-二[二(3, 5-二甲苯基)膦基]-1, 1'-联萘基}[(1R, 2R)-(+)-1, 2-二苯基乙烯二胺]钌(II) [<xref ref-type="bibr" rid="hanspub.21876-ref3">3</xref>] ，二氯双(4-甲基异丙基苯基)钌(II) [<xref ref-type="bibr" rid="hanspub.21876-ref4">4</xref>] 等。所报道的酶来源于圆红冬孢酵母菌 [<xref ref-type="bibr" rid="hanspub.21876-ref5">5</xref>] 、酿酒酵母(CGMCC No. 2230) [<xref ref-type="bibr" rid="hanspub.21876-ref6">6</xref>] 、L-肉碱还原酶 [<xref ref-type="bibr" rid="hanspub.21876-ref7">7</xref>] 、羰基还原酶(SEQ ID NO: 28) [<xref ref-type="bibr" rid="hanspub.21876-ref8">8</xref>] 、壳聚糖 [<xref ref-type="bibr" rid="hanspub.21876-ref9">9</xref>] 等。</p><p>该工艺是目前研究较热门的方向，其具有收率高、步骤短、反应温和，具有潜在的工业化价值。但问题在于采用酶或者金属不对称催化剂会导致成本较高。</p></sec><sec id="s4_1_2"><title>2.1.2. 甲胺保护基法</title><p>此法将乙酰噻吩、三聚甲醛或多聚甲醛和甲胺衍生物通过Mannich法合成相应的(S)-3-甲基氨基-1-(噻吩-2-基)丙酮衍生物，通过不对称催化剂还原得到相应的(S)-3-甲基氨基-1-(噻吩-2-基)丙醇衍生物，再通过水解或还原得到目标产物(图3)。其中R保护基为甲酸乙酯基、三氟乙酰基、羟基、甲氧基或者苯乙基，所用的不对称催化剂是(S, S)-N-(对甲苯磺酰)-1, 2-二苯乙烷二胺(对异丙基苯)氯化钌(II) [<xref ref-type="bibr" rid="hanspub.21876-ref10">10</xref>] 、二氯(对甲基异丙苯)钌(II) [<xref ref-type="bibr" rid="hanspub.21876-ref4">4</xref>] 、R-2-甲基-CBS-恶唑硼烷 [<xref ref-type="bibr" rid="hanspub.21876-ref11">11</xref>] 或Ni[(R)-2, 2'-双(二苯基磷)-1, 1'-联苯]二氧化钌 [<xref ref-type="bibr" rid="hanspub.21876-ref12">12</xref>] 。当R基是甲酸乙酯基、三氟乙酰基或苯乙基时，可用氢氧化钾 [<xref ref-type="bibr" rid="hanspub.21876-ref10">10</xref>] 或者碳酸钠 [<xref ref-type="bibr" rid="hanspub.21876-ref4">4</xref>] 进行脱保护；当R是羟基或者甲氧基，可用锌粉/醋酸 [<xref ref-type="bibr" rid="hanspub.21876-ref13">13</xref>] 或者镍粉 [<xref ref-type="bibr" rid="hanspub.21876-ref14">14</xref>] 进行脱保护基。</p><p>此法具有较好的专一性，副产物较少，但是由于保护基的存在，使得原料成本和步骤增长，成本增加。</p></sec><sec id="s4_1_3"><title>2.1.3. 乙酰噻吩溴代法</title><p>此法将乙酰噻吩先与N-溴代琥珀酰亚胺(NBS) [<xref ref-type="bibr" rid="hanspub.21876-ref15">15</xref>] 、液溴 [<xref ref-type="bibr" rid="hanspub.21876-ref16">16</xref>] 或者溴化亚铜 [<xref ref-type="bibr" rid="hanspub.21876-ref17">17</xref>] 反应得到溴代乙酰噻吩，在不对称催化剂氯化(均三甲苯)[(S, S)-N-(对甲苯磺酰基)-1, 2-二苯乙烯基二胺]钌(II) (RhCl[(S, S)- TsDPEN])的作用下得到具有R构型的醇，然后用硼烷二甲硫醚络合物还原得到噻吩丙胺醇，通过N'N-</p><p>图2. 以甲胺盐酸盐为原料的合成路线</p><p>图3. 以甲胺衍生物为原料的合成路线</p><p>羰基二咪唑(CDI)发生分子内缩合得到相应内酰胺化合物，其可以在氢化钠作用下与碘甲烷反应得到目标产物 [<xref ref-type="bibr" rid="hanspub.21876-ref18">18</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref20">20</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref21">21</xref>] (图4)。</p></sec></sec><sec id="s4_2"><title>2.2. 噻吩法</title><p>以噻吩为原料，先与3-氯丙酰氯发生傅克反应得到2-(氯丙酰基)噻吩 [<xref ref-type="bibr" rid="hanspub.21876-ref22">22</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref23">23</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref24">24</xref>] ，以此为原料有两条合成路线，分别是叠氮转化法和直接还原法。</p><sec id="s4_2_1"><title>2.2.1. 叠氮转化法</title><p>此法在合成2-(氯丙酰基)噻吩的基础上，通过与叠氮化钠和硼氢化钠还原得到噻吩叠氮醇，再在脂肪酶作用下转化为立体异构体，然后在10%Pd-C还原下得到噻吩氨基醇，再与氯甲酸乙酯反应将氨基酯化，最后再四氢铝锂作用下得到目标产物 [<xref ref-type="bibr" rid="hanspub.21876-ref24">24</xref>] (图5)。</p></sec><sec id="s4_2_2"><title>2.2.2. 直接还原法</title><p>2-(氯丙酰基)噻吩直接用脂肪酶还原为噻吩氯代丙醇，然后再与甲胺反应得到目标产品 [<xref ref-type="bibr" rid="hanspub.21876-ref23">23</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref25">25</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref26">26</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref27">27</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref28">28</xref>] [<xref ref-type="bibr" rid="hanspub.21876-ref29">29</xref>] (图6)。</p><p>图4. 以乙酰噻吩为原料的合成路线</p><p>图5. 以噻吩为原料的合成路线I</p><p>图6. 以噻吩为原料的合成路线II</p><p>图7. 以噻吩甲醛为原料的合成路线</p></sec></sec><sec id="s4_3"><title>2.3. 噻吩甲醛法</title><p>此合成路线是以噻吩甲醛为原料，与N, N-二烯丙基硫代乙酰胺通过组合催化剂[六氟磷酸四乙腈铜(Cu(CH3CN)4PF6), 1, 2-双((2S, 5S)-2, 5-二苯基膦)乙烷((S, S)-Ph-BPE)和对甲氧基苯氧基锂(Li(OC6H4-p-OMe))]得到R构型的硫代烯丙基胺噻吩醇，再通过四氢铝锂还原，氯甲酸甲酯酯化和四氢铝锂还原三步得到目标产物 [<xref ref-type="bibr" rid="hanspub.21876-ref30">30</xref>] (图7)。</p></sec></sec><sec id="s5"><title>3. 总结</title><p>本文基于合成(S)-3-甲基氨基-1-(噻吩-2-基)丙醇起始原料，将其合成方法分为乙酰噻吩法、噻吩法和噻吩甲醛法。由于噻吩法和噻吩甲醛法按照现有的工艺由于成本高，收率较低(20%~50%)，因而离工业化还较远；而乙酰噻吩法由于路线短，收率较高(60%~80%)，将是今后工业化的发展方向。而所有方法关键点都在于如何将羰基直接转化成手性羟基的方法。一般用到的不对称催化剂有两大类，分别是金属不对称催化剂和酶催化剂，前者由于成本较高，还未有大范围的工业化；而后者由于反应温和又环保，且随着生物技术的提高，其工业化的潜力将越来越大。</p></sec><sec id="s6"><title>基金项目</title><p>2016年台州市科技计划项目(162gy57)；台州市“211”人才工程资助项目。</p></sec><sec id="s7"><title>文章引用</title><p>吴佳佳,季程宇,谢童杰,马良秀,郝之奎,徐 峰. 度洛西汀中间体(S)-3-甲基氨基-1-(噻吩-2-基)丙醇合成工艺综述Overview on the Synthesis of (S)-3-(Methyl-Amino)-1-(Thiophen-2-yl) Propan-1-ol[J]. 化学工程与技术, 2017, 07(05): 199-204. http://dx.doi.org/10.12677/HJCET.2017.75029</p></sec><sec id="s8"><title>参考文献 (References)</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.21876-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">李龙, 邱贵森, 蒋泰龙, 等. 化学酶法合成盐酸度洛西汀的研究进展[J]. 化工进展, 2014, 33(7): 1839-1843.</mixed-citation></ref><ref id="hanspub.21876-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Lonza, A.G. (2005) Process for the Asymmetric Hydrogenation of β-Amino Ketones Using Transition Metal Complexes of Chiral Bidentate Phosphines as Catalysts. EP1510517, 2005-03-02.</mixed-citation></ref><ref id="hanspub.21876-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Yokozawa, T. and Yagi, K. (2004) Preparation of Optically Active Amino Alcohols by Asymmetric Hydrogenation of Enaminones. EP1411045, 2004-04-21.</mixed-citation></ref><ref id="hanspub.21876-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Mohar, B. (2010) Process for Preparation of Duloxetine via Asymmetric Transfer Hydrogenation of β-Ketoamines. EP2010003942, 2010-01-14.</mixed-citation></ref><ref id="hanspub.21876-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Chen, X., Liu, Z.-Q. and Lin, C.-P. (2016) Chemoenzymatic Synthesis of (S)-Duloxetine Using Carbonyl Reductase from Rhodosporidium toruloides. Bioorganic Chemistry, 65, 82-89. &lt;br&gt;https://doi.org/10.1016/j.bioorg.2016.02.002</mixed-citation></ref><ref id="hanspub.21876-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Qu, Z.-M., Zhao, H.-B. and Lan, T. (2014) Asymmetric Synthesis of Duloxetine Intermediate (S)-(-)-3-Nmethylamino- 1-(2-thienyl)-1-Propanol Using Immobilized Saccharomyces cerevisiae in Liquid-Core Sodium Alginate/Chitosan/ Sodium Alginate Microcapsules. Bioprocess and Biosystems Engineering, 37, 2243-2250.  
&lt;br&gt;https://doi.org/10.1007/s00449-014-1202-9</mixed-citation></ref><ref id="hanspub.21876-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">H•阿尔特费赫, M•凯塞勒. L-肉碱脱氢酶、其衍生物以及取代的(S)-链烷醇的制备. CN1771323.2006-05-10.</mixed-citation></ref><ref id="hanspub.21876-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Savile, C., Gruber, J.M. and Mundorff, E. (2013) Polynucleotides Encoding Engineered Ketoreductase Polypeptides. US2013005017, 2013-01-03.</mixed-citation></ref><ref id="hanspub.21876-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ou, Z.-M. (2014) Asymmetric Synthesis of Duloxetine Intermediate (S)-(-)-3-N-methylamino-1-(2-thienyl)-1-propanol Using Immobilized Saccharomyces cerevisiae in Liquid-Core Sodium Alginate/Chitosan/Sodium Alginate Microcapsules. Bioprocess &amp; Biosystems Engineering, 37, 2243-2250.</mixed-citation></ref><ref id="hanspub.21876-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">赵金凤, 窦海建, 周宇涵, 等. (S,S)-TsDPEN-Ru催化不对称氢转移还原β-胺基酮及在度洛西汀合成中的应用[J]. 高等学校化学学报, 2011, 32(10): 2331-2334.</mixed-citation></ref><ref id="hanspub.21876-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Pospisilik, K. and Dymacek, B. (2008) Process for Preparation of Duloxetine and Intermediates Thereof. WO 2008077645, 2008-07-03.</mixed-citation></ref><ref id="hanspub.21876-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Chen, B.-F. and Yeh, J.-B. (2009) Preparation of Optically Active Methylhydroxylaminopropanol Derivative and Its Use as Intermediate for Preparation of (S)-(-)-3-methylamino-1-(2-thienyl)propan-1-ol. US 20090112001, 2009-04-30.</mixed-citation></ref><ref id="hanspub.21876-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Pospisilik, K. and Dymacek, B. (2008) Process for Preparation of Duloxetine and Intermediates Thereof. WO2008077645, 2008-07-03.</mixed-citation></ref><ref id="hanspub.21876-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Chen, B.-F. (2011) Process for Preparing (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine by Using an Optically Active Methylhydroxyaminopropanol Compound as an Intermediate. WO2386549, 2011-11-16.</mixed-citation></ref><ref id="hanspub.21876-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Guan, X.-Y., Al-Misba’a, Z. and Huang, K.-W. (2015) Efficient and Selective α-bromination of Carbonyl Compounds with N-Bromosuccinimide under Microwave. Arabian Journal of Chemistry, 8, 892-896.</mixed-citation></ref><ref id="hanspub.21876-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Chen, J.-Z., Liu, D.-L. and Butt, N. (2013) Palladium-Catalyzed Asymmetric Hydrogenation of α-Acyloxy-1-arylethanones. Angewandte Chemie, International Edition, 52, 11632-11636.  
&lt;br&gt;https://doi.org/10.1002/anie.201306231</mixed-citation></ref><ref id="hanspub.21876-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Aeluri, R., Alla, M. and Polepalli, S. (2015) Synthesis and Antiproliferative Activity of Imidazo[1,2-a] Pyrimidine Mannich Bases. European Journal of Medicinal Chemistry, 100, 18-23.</mixed-citation></ref><ref id="hanspub.21876-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Venkatram, R., Pai, V.K. and Nagaraj, S. (2011) Stereoselective Synthesis and Dissolution Studies on Enteric Coated Pellets of (S)-duloxetine Hydrochloride. Journal of Nepal Chemical Society, 28, 74-79.</mixed-citation></ref><ref id="hanspub.21876-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Lee, G.I., Lee, D.M. and Kwak, S.H. (2011) Optically Active 2-Sulfonyloxy-1-heteroarylethanol Derivative, and Method for the Preparation of Heteroaryl-Aminoalcoholtherefrom. KR 2011006389, 2011-01-20.</mixed-citation></ref><ref id="hanspub.21876-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Venkatram, R., Pai, V.K. and Nagaraj, S. (2013) Novel Enantioselective Synthesis and Dissolution Studies on Enteric Coated Pellets of (S)-Duloxetine Hydrochloride. Bulgarian Chemical Communications, 45, 269-273.</mixed-citation></ref><ref id="hanspub.21876-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Raghunandan, H.V., Pai, V.K. and Dixit, M. (2012) Synthesis, Formulation and Characterization of Physico-Chemical Property and Dissolution of Enteric Coated Pellets of (s)-Duloxetine Hydrochloride. Elixir Online Journal, 11, 11376-11380.</mixed-citation></ref><ref id="hanspub.21876-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Stuermer, R., Kesseler, M. and andHauer, B. (2005) Enzymic and Nonenzymic Methods for the Preparation of 3-Methylamino-1-(thien-2-yl)propan-1-ol. WO2005033094, 2005-04-14.</mixed-citation></ref><ref id="hanspub.21876-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Lee, G.I., Lee, S.A. and Hwang, I.T. (2016) Method for Preparation of 3-Amino-1-aryl-1-ol Derivatives from Optically Active 3-chloro-1-aryl-1-ol Derivatives. KR 2016044117, 2016-04-25.</mixed-citation></ref><ref id="hanspub.21876-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Kamal, A., Malik, M.S. and Shaik, A.A. (2009) Lipase Mediated Resolution of γ-Azidoalcohols in Aqueous and Organic Media: Synthesis of (R)- and (S)-fluoxetine and Duloxetine. Journal of Molecular Catalysis B: Enzymatic, 58, 132-137.</mixed-citation></ref><ref id="hanspub.21876-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Lee, G.I., Lee, S.A. and Hwang, I.T. (2015) Optically Active 3-Amino-1-propanol Derivative and Preparation of (S)-Duloxetine Thereby. KR2015043955, 2015-04-23.</mixed-citation></ref><ref id="hanspub.21876-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Lee, S.-A., Sadu, V.S. and Park, N.-J. (2014) A Practical Synthesis of the Antidepressant (S)-Duloxetine. Bulletin of the Korean Chemical Society, 35, 1894-1896. &lt;br&gt;https://doi.org/10.5012/bkcs.2014.35.6.1894</mixed-citation></ref><ref id="hanspub.21876-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Kawano, S., Yasohara, Y. and Onodera, K. (2010) Process for Enzymic Production of (S)-1-substituted Propan-1-ol Derivatives. WO 2010123067, 2010-10-28.</mixed-citation></ref><ref id="hanspub.21876-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Stuermer, R. (2005) A Chemoenzymic Synthesis of Enantiomerically Pure Aminoalcohols. WO2005073215, 2005-08-11</mixed-citation></ref><ref id="hanspub.21876-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Modi, I.A., Shukla, M.C. and Kagathara, N.K. (2009) Process for the Preparation of Enantiomerically Pure 3-hydroxy-3-arylpropylamines and Their Optical Stereoisomers. EP2060559, 2009-03-20.</mixed-citation></ref><ref id="hanspub.21876-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Iwata, M. and Yazaki, R. (2012) Concise Enantioselective Synthesis of Duloxetine via Direct Catalytic Asymmetric Aldol Reaction of Thioamidesuzuki. Journal of Organic Chemistry, 77, 4496-4500. &lt;br&gt;https://doi.org/10.1021/jo300566p</mixed-citation></ref></ref-list></back></article>